Optimal use of contrast echo in daily practice: what do we need?
With new low power imaging and contrast application technology, it seems possible for the first time to develop a protocol that combines acquisition of both function and perfusion data using a simple modality. For this purpose a European network has been created and this group is currently developing a protocol using a commercially available ultrasound scanner and the infusion of the echocontrast agent SonoVue (Bracco). This study describes the technical developments that will promote a comprehensive clinical contrast protocol for assessment of patients with ischemic heart disease.